established a molecular stratification model for prognosis in 121 patients with cytogenetically normal AML, and high PRAME, low ERG and low EVI1 were assigned as favorable parameters that were associated with longer relapse-free survival (RFS) and overall survival (OS). Here, RUNX1 is linked to acute myeloid leukemia.